(Q37624271)

21 August 2017

Six-month freedom from treatment failure is an important end point for acute GVHD clinical trials (English)

1 reference

21 August 2017

S Sengsayadeth

1

1 reference

21 August 2017

B N Savani

2

1 reference

21 August 2017

M Jagasia

3

1 reference

21 August 2017

S Goodman

4

1 reference

21 August 2017

J P Greer

5

1 reference

21 August 2017

H Chen

6

1 reference

21 August 2017

W Chinratanalab

7

1 reference

21 August 2017

A A Kassim

8

1 reference

21 August 2017

B G Engelhardt

9

1 reference

21 August 2017

language of work or name

English

0 references

publication date

7 October 2013

1 reference

Bone Marrow Transplantation

21 August 2017

1 reference

21 August 2017

49

1 reference

21 August 2017

2

1 reference

21 August 2017

236-240

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2013.157

21 August 2017

0 references

cites work

Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946331

First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946331

Novel treatment concepts for graft-versus-host disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946331

Prognostic value of response after upfront therapy for acute GVHD

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946331

Graft-versus-host disease treatment: predictors of survival

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946331

Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946331

Study design and endpoints in graft-versus-host disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946331

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946331

1994 Consensus Conference on Acute GVHD Grading

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946331

The best endpoint for acute GVHD treatment trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3946331

1 September 2018

Identifiers

DOI

10.1038/BMT.2013.157

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

24096824

1 reference